Bristol-Myers Squibb: Declines Have Gone Too Far

Group 1 - Bristol-Myers Squibb Company (NYSE: BMY) has experienced significant losses in 2025, with year-to-date losses exceeding 20% [1] - This performance is particularly disappointing when compared to the S&P 500, which has increased by approximately 13% during the same period [1] - The company has reported earnings, but specific details regarding the earnings were not provided in the document [1]